ExcepGen is focused on developing RNA-based vaccines that improve tolerability by dampening excessive innate immune responses
ExcepGen is focused on developing RNA-based vaccines that improve tolerability by dampening excessive innate immune responses. Their RNAx platform aims to alter cellular responses to nucleic acids, enhancing the effectiveness of mRNA vaccines.